Are Billion Dollar Settlements the New Normal?


The Philadelphia Inquirer writes on the reported $2.2 billion Johnson & Johnson Risperdal settlement, the $2.3 billion Pfizer Geodon penalty, the $3 billion GlaxoSmithKline Avandia settlement, and the fact that “no human being, apparently, is going to be held responsible for substantial criminal activity by a corporation.”

Article → 


Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articleHolistic Recovery From Schizophrenia: A Mother and Son’s Journey
Next articleTemperature-Related Deaths in People with Mental Illness
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]